Copaxone is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Teva Neuroscience, Inc.. The primary component is Glatiramer Acetate.
| Product ID | 68546-325_04f9ea25-0d45-4e44-8ed8-dc61db4f5466 |
| NDC | 68546-325 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Copaxone |
| Generic Name | Glatiramer Acetate |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2014-01-29 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020622 |
| Labeler Name | Teva Neuroscience, Inc. |
| Substance Name | GLATIRAMER ACETATE |
| Active Ingredient Strength | 40 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2014-01-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020622 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2014-01-29 |
| Marketing Category | NDA |
| Application Number | NDA020622 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2014-01-29 |
| Ingredient | Strength |
|---|---|
| GLATIRAMER ACETATE | 40 mg/mL |
| SPL SET ID: | aa88f583-4f5f-433b-80b4-1f4c9fb28357 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 68546-317 | Copaxone | Glatiramer Acetate |
| 68546-325 | Copaxone | Glatiramer Acetate |
| 0378-6960 | Glatiramer Acetate | glatiramer acetate |
| 0781-3234 | Glatopa | Glatiramer Acetate |
| 0781-3250 | Glatopa | Glatiramer Acetate |
| 63629-8815 | Glatopa | Glatiramer Acetate |
| 63629-8816 | Glatopa | Glatiramer Acetate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() COPAXONE 74348964 1816603 Live/Registered |
TEVA PHARMACEUTICAL INDUSTRIES LTD. 1993-01-15 |